These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3840850)

  • 1. Increase of the ventricular fibrillation threshold by 711389-S, a new antiarrhythmic agent, in guinea-pigs.
    Nakajima S; Ueda M
    Jpn J Pharmacol; 1985 Aug; 38(4):436-8. PubMed ID: 3840850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antifibrillatory potency of aprindine, mexiletine, tocainide and lignocaine compared on Langendorff-perfused hearts of rabbits and guinea-pigs.
    Almotrefi AA; Baker JB
    J Pharm Pharmacol; 1980 Nov; 32(11):746-50. PubMed ID: 6110721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Symposium on the management of ventricular dysrhythmias. Antifibrillatory versus antiectopic therapy.
    Anderson JL
    Am J Cardiol; 1984 Jul; 54(2):7A-13A. PubMed ID: 6147079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined application of class I antiarrhythmic drugs causes "additive", "reductive", or "synergistic" sodium channel block in cardiac muscles.
    Kawamura T; Kodama I; Toyama J; Hayashi H; Saito H; Yamada K
    Cardiovasc Res; 1990 Nov; 24(11):925-31. PubMed ID: 2176934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of negative inotropic and antiarrhythmic effects of class 1 antiarrhythmic drugs.
    Nawada T; Tanaka Y; Hirai S; Hisatome I; Hasegawa J; Kotake H; Mashiba H
    Int J Clin Pharmacol Ther; 1994 Jul; 32(7):347-55. PubMed ID: 7952796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antifibrillary action of class I-IV antiarrhythmic agents in the model of ventricular fibrillation threshold of anesthetized guinea pigs.
    Lu HR; Remeysen P; De Clerck F
    J Cardiovasc Pharmacol; 1995 Jul; 26(1):132-6. PubMed ID: 7564354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of antiarrhythmic drugs on the repetitive extrasystole threshold and the ventricular fibrillation threshold.
    Murakawa Y; Toda I; Nozaki A; Kawakubo K; Sugimoto T
    Cardiology; 1989; 76(1):58-66. PubMed ID: 2468414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opposite change with ischaemia in the antifibrillatory effects of class I and class IV antiarrhythmic drugs resulting from the alteration in ion transmembrane exchanges related to depolarization.
    Aupetit JF; Bui-Xuan B; Kioueh I; Loufoua J; Frassati D; Timour Q
    Can J Physiol Pharmacol; 2000 Mar; 78(3):208-16. PubMed ID: 10721812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Influence of antifibrillatory drugs on electric elementary processes].
    Fleckenstein A
    Verh Dtsch Ges Kreislaufforsch; 1969; 35():77-87. PubMed ID: 4985686
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of etafenone and antiarrhythmic drugs on Na and Ca channels of guinea pig atrial muscle.
    Hashimoto K; Satoh H; Imai S
    J Cardiovasc Pharmacol; 1979; 1(5):561-70. PubMed ID: 94412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrophysiological effects of 711389-S, a new antiarrhythmic agent, on guinea-pig isolated cardiac muscle.
    Ninomiya M; Toyama J; Kodama I; Yamada K
    J Cardiovasc Pharmacol; 1984; 6(6):1222-9. PubMed ID: 6084783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antifibrillatory and profibrillatory actions of selected class I antiarrhythmic agents.
    Fagbemi SO; Chi L; Lucchesi BR
    J Cardiovasc Pharmacol; 1993 May; 21(5):709-19. PubMed ID: 7685439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effects of antiarrhythmic drugs on the ventricular fibrillation threshold.
    Euler DE; Scanlon PJ
    J Cardiovasc Pharmacol; 1988 Mar; 11(3):291-8. PubMed ID: 2452921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Negative inotropic effects of tetrodotoxin and seven class 1 antiarrhythmic drugs in relation to sodium channel blockade.
    Honerjäger P; Loibl E; Steidl I; Schönsteiner G; Ulm K
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Feb; 332(2):184-95. PubMed ID: 2422563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined class I antiarrhythmic agents have differential effects on tonic and use dependent block of maximum rate of depolarisation of action potentials in guinea pig cardiac muscle.
    Nitta J; Sunami A; Furukawa T; Marumo F; Sawanobori T; Hiraoka M
    Cardiovasc Res; 1992 May; 26(5):462-9. PubMed ID: 1332827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrophysiologic, antiarrhythmic and hemodynamic effects of transcainide.
    Carmeliet E; Janssen PA; Heykants J; Niemegeers CJ; Remeysen P; Van De Water A; Van Gerven W; Wauquier A; Xhonneux R
    Arch Int Pharmacodyn Ther; 1987 Jun; 287(2):272-90. PubMed ID: 3632145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of S-1389 (711389-S), a new antiarrhythmic agent, on the conduction in perfused guinea pig hearts.
    Ninomiya M; Tani T; Ueda M
    Jpn J Pharmacol; 1989 Dec; 51(4):555-62. PubMed ID: 2615048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ventricular fibrillation threshold measured by continuous 50 cps stimulation for the evaluation of the antifibrillatory effect of the drugs.
    Toda I; Murakami Y; Nozaki A; Kawakubo K; Sugimoto T
    Jpn Circ J; 1988 Mar; 52(3):249-53. PubMed ID: 3373716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of 711389-S, a new antiarrhythmic agent, on myocardial energy metabolism in guinea-pigs and rats.
    Iwaki K; Ishii M; Shinosaki T; Ueda M; Yonetani Y
    J Pharm Pharmacol; 1988 Jan; 40(1):10-6. PubMed ID: 2896767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrophysiological properties of a new antiarrhythmic agent, bisaramil on guinea-pig, rabbit and canine cardiac preparations.
    Sunami A; Sawanobori T; Adaniya H; Hiraoka M
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Sep; 344(3):323-30. PubMed ID: 1961258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.